|Follow us :|
Luai Al Bakour
El Temamy Pharmacy
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ
Britton Chance Center for Biomedical Photonics
Arabian Trade Center - ATC
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
MainYou must sign in to use this servcie
Feedback - Please use the form below to send your query or comment
You must sign in to use this servcie
Moderate to severe pain of any origin: tension headache, migraine, dental pain, post-op pain, dysmenorrhoea, cancer pain, low back pain, fever & also symptomatic relief from colds and cough.
Renal & hepatic failure. Pregnancy & lactation.
Very rarely (and usually mild) skin rashes and palpitations. Sedation and dizziness may occur after the intake of the yellow (night) tablet. In this case it is not advisable for patients who drive or operate machinery at night. Therefore the yellow tablet is recommended at bedtime.
Acetaminophen is metabolized (eliminated by conversion to other chemicals) by the liver. Therefore drugs that increase the action of liver enzymes that metabolize acetaminophen [for example, carbamazepine (Tegretol), isoniazid (INH, Nydrazid, Laniazid), rifampin (Rifamate, Rifadin, Rimactane)] reduce the levels of acetaminophen and may decrease the action of acetaminophen. Doses of acetaminophen greater than the recommended doses are toxic to the liver and may result in severe liver damage. The potential for acetaminophen to harm the liver is increased when it is combined with alcohol or drugs that also harm the liver. Cholestyramine (Questran) reduces the effect of acetaminophen by decreasing its absorption into the body from the intestine. Therefore, acetaminophen should be administered 3 to 4 hours after cholestyramine or one hour before cholestyramine . Acetaminophen doses greater than 2275 mg per day may increase the blood thinning effect of warfarin (Coumadin) by an unknown mechanism. Therefore, prolonged administration or large doses of acetaminophen should be avoided during warfarin therapy
Caution should be taken with patients suffering from hyperthyroidism, hypertension, coronary insufficiency and diabetes mellitus. It should not be used concurrently with MAO inhibitors . It may be used after two weeks of stopping the MAO inhibitor-therapy.
Dosage and AdministrationYou must sign in to use this servcie
Technical DescriptionYou must sign in to use this servcie
Dr. Hani Najjar
Yaser Habrawi , F.R.C.S.Ed
Dr. Tahsin Martini
Dr . Dirar Abboud
Dr. Faisal Dibsi
Samir Moussa M.D.
Dr. Talal Sabouni
Dr. Samer Al-Jneidy